Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intravenous ketamine plus morphine for refractory cancer pain
2006-002024-41Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine and morphine in cancer pain (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Change in mean daily pain intensity score. Started Jul 2006; status: active.
02
Drugs
ketaminemorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2006-002024-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002024-41.